AKRO insider buying – Akero Therapeutics, Inc.
12 insider purchases since 2016 worth $85.0M by 6 different insiders. Last 12 months: 0 purchases, $0. Most recent filing: 2025-03-27.
Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits. 5 older purchases (before the 5-year window) are listed in the table below.
Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.
Bought, sold, still holding?
| Insider | Bought | First / last buy | Sold since 2016 | Holds now* | Status |
|---|---|---|---|---|---|
| Graham G. Walmsley Director | $40.9M 7× · 1,200,000 sh | 2023-05-19 2025-03-25 | – | 0 shares as of 2025-12-09 | Sold everything |
| Harrison Seth Loring Director | $14.9M 1× · 415,000 sh | 2020-07-10 2020-07-10 | 3× · $15.1M last 2022-11-30 | 0 shares as of 2025-12-09 | Sold everything |
| ATP III GP, Ltd. 10% Owner | $14.4M 1× · 900,000 sh | 2019-06-24 2019-06-24 | – | 5,830,203 shares as of 2020-07-14 | Holds - never sold |
| Versant Venture Capital VI, L.P. 10% Owner | $6.4M 1× · 400,000 sh | 2019-06-24 2019-06-24 | 3× · $10.7M last 2019-12-27 | 3,673,792 shares as of 2019-12-31 | Sold part |
| Atlas Venture Associates Opportunity I, LLC 10% Owner | $4.3M 1× · 270,000 sh | 2019-06-24 2019-06-24 | – | 505,099 shares as of 2019-06-25 | Holds - never sold |
| venBio Global Strategic GP II, Ltd. 10% Owner | $4.0M 1× · 250,000 sh | 2019-06-24 2019-06-24 | – | 3,954,858 shares as of 2019-06-25 | Holds - never sold |
* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.
Insider buying and selling by year
| Year | Purchases | Bought | Buyers | Sales | Sold |
|---|---|---|---|---|---|
| 2025 | 2 | $18.4M | 1 | 52 | $39.7M |
| 2024 | 0 | – | – | 38 | $26.6M |
| 2023 | 5 | $22.5M | 1 | 24 | $24.8M |
| 2022 | 0 | – | – | 27 | $100.6M |
| 2021 | 0 | – | – | 28 | $7.9M |
| 2020 | 1 | $14.9M | 1 | 17 | $26.2M |
| 2019 | 4 | $29.1M | 4 | 3 | $10.7M |
Insider purchases
| Filed | Insider | Role | Shares | Avg price | Value | Holdings | Filing |
|---|---|---|---|---|---|---|---|
| 2025-03-27 | Graham G. Walmsley | Director | 200,000 | $43.94 | $8.8M | +20.0% | SEC |
| 2025-02-07 | Graham G. Walmsley | Director | 200,000 | $48.00 | $9.6M | +25.0% | SEC |
| 2023-12-11 | Graham G. Walmsley | Director | 100,000 | $19.82 | $2.0M | +14.3% | SEC |
| 2023-12-05 | Graham G. Walmsley | Director | 100,000 | $16.95 | $1.7M | +16.7% | SEC |
| 2023-08-10 | Graham G. Walmsley | Director | 25,000 | $42.06 | $1.1M | +4.3% | SEC |
| 2023-08-01 | Graham G. Walmsley | Director | 55,000 | $42.95 | $2.4M | +10.6% | SEC |
| 2023-05-23 | Graham G. Walmsley | Director | 520,000 | $29.69 | $15.4M | SEC | |
| 2020-07-14 | Harrison Seth Loring | Director | 415,000 | $36.00 | $14.9M | +7.7% | SEC |
| 2019-06-25 | venBio Global Strategic GP II, Ltd. | 10% Owner | 250,000 | $16.00 | $4.0M | SEC | |
| 2019-06-25 | Versant Venture Capital VI, L.P. | 10% Owner | 400,000 | $16.00 | $6.4M | +10.8% | SEC |
| 2019-06-25 | Atlas Venture Associates Opportunity I, LLC | 10% Owner | 270,000 | $16.00 | $4.3M | +114.8% | SEC |
| 2019-06-25 | ATP III GP, Ltd. | 10% Owner | 900,000 | $16.00 | $14.4M | +19.9% | SEC |
Insider sales
| Filed | Insider | Role | Shares | Avg price | Value | Type | Filing |
|---|---|---|---|---|---|---|---|
| 2025-10-14 | Cheng Andrew | CEO | 30,000 | $53.98 | $1.6M | Sale | SEC |
| 2025-10-09 | Rolph Timothy | Officer | 12,500 | $46.08 | $575,965 | Sale | SEC |
| 2025-10-03 | Young Jonathan | Officer | 12,500 | $47.75 | $596,928 | Sale | SEC |
| 2025-09-12 | Cheng Andrew | CEO | 31,796 | $43.23 | $1.4M | Sale | SEC |
| 2025-09-10 | Rolph Timothy | Officer | 12,500 | $44.17 | $552,149 | Sale | SEC |
| 2025-09-04 | Young Jonathan | Officer | 12,500 | $46.09 | $576,085 | Sale | SEC |
| 2025-08-13 | Young Jonathan | Officer | 12,500 | $47.78 | $597,309 | Sale | SEC |
| 2025-08-13 | Cheng Andrew | CEO | 30,000 | $48.59 | $1.5M | Sale | SEC |
| 2025-08-12 | Henderson Jane | Director | 3,000 | $47.46 | $142,380 | Sale | SEC |
| 2025-08-07 | Rolph Timothy | Officer | 12,500 | $49.30 | $616,299 | Sale | SEC |
| 2025-07-18 | Yale Catriona | Officer | 10,000 | $52.95 | $529,505 | Sale | SEC |
| 2025-07-11 | Cheng Andrew | CEO | 30,000 | $51.16 | $1.5M | Sale | SEC |
| 2025-07-09 | Rolph Timothy | Officer | 12,500 | $51.09 | $638,647 | Sale | SEC |
| 2025-07-03 | Lamy Patrick | Officer | 2,000 | $52.88 | $105,760 | Sale | SEC |
| 2025-06-20 | Young Jonathan | Officer | 1,453 | $54.84 | $79,683 | Sale | SEC |
Showing the latest 15 of 189 sales of $50,000+ since 2016.
Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.
Get every new insider purchase the day it's filed
Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.
Get started free